TickerFacts.

Earth Science Tech, Inc. (ETST): Cash & Equivalents

Annual figures by period end, from SEC filings.

$796.8K
As of 2026-03-31
$631.1K
As of 2026-06-30
+181.4%
3-year compound annual growth
+118.1%
5-year compound annual growth
$1.47M2020-03-31: $30.7K2021-03-31: $16.2K2022-03-31: $26.9K2023-03-31: $35.8K2025-03-31: $1.47M2026-03-31: $796.8K$796.8K
2020-03-31 Cash & Equivalents (USD) 2026-03-31
Period endedCash & EquivalentsChange YoYSource filing
2026-03-31$796.8K-45.9%2026-06-18, Balance as of period end
2025-03-31$1.47Mn/a2026-06-18, Balance as of period end
No annual figure between 2023-03-31 and 2025-03-31.
2023-03-31$35.8K+32.7%2024-02-27, Balance as of period end
2022-03-31$26.9K+66.7%2024-02-27, Balance as of period end
2021-03-31$16.2K-47.4%2022-07-22, Balance as of period end
2020-03-31$30.7Kn/a2022-02-22, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Earth Science Tech, Inc. (ETST)2026-03-31$796.8K-45.9%
Verrica Pharmaceuticals Inc. (VRCA)2025-12-31$30.15M-34.9%
Lftd Partners Inc. (LIFD)2025-12-31$1.77M-17.7%
Bioharvest Sciences Inc. (BHST)2025-12-31$23.02M+863.4%
BGM Group Ltd. (BGM)2025-09-30$9.82M0.0%
Zomedica Corp. (ZOMDF)2025-12-31$9.02M+28.4%
Verastem, Inc. (VSTM)2025-12-31$204.99M+130.8%
Foghorn Therapeutics Inc. (FHTX)2025-12-31$80.88M+45.8%
Biofrontera Inc. (BFRI)2025-12-31$6.39M+8.2%

Compare ETST, VRCA, LIFD, BHST side by side · Screen every company in Pharmaceutical Preparations ↗